Table 3 Immunohistochemical results among different groups of lung cancer
Stage | Class | T/NT (1 h) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
I-II (n = 21) | III-IV (n = 45) | p | LAC (n = 34) | LSC (n = 26) | SCLC (n = 6) | p | low (< 7.21) (n = 33) | high (≥ 7.21) (n = 33) | p | |
Integrin αvβ3 (OD) | 5914.4 (1461.6, 17,658.2) | 19,729.0 (6445.4, 45,288.3) | 3.10E-02 | 17,308.1 (7973.6,47,755.9) | 9721.6 (3186.5,23,010.7) | 6485.0 (3083.0,28,119.0) | 0.31 | 16,958.0 (3842.8,36,479.0) | 12,235.4 (4935.2,47,323.5) | 0.98 |
CXCR4 (OD) | 8438.0 (2582.5,22,821.8) | 4002 (1863,11,541) | 0.18 | 4536 (1348,10,501) | 9052.0 (3688.9,33,442.9) | 2324 (1980,4395) | 0.11 | 6561.00 (2049.20,18,854.50) | 5007 (1335,15,314) | 0.65 |
CD31 (MVD) | 28.20 (14.25,34.40) | 21.33 (13.75,32.00) | 0.54 | 27.80 (14.44,34.35) | 19.72 (15.06,32.11) | 13.32 (11.75,20.04) | 0.25 | 25.80 (15.00,35.40) | 18.20 (13.75,28.40) | 0.25 |
Ki67 (%) | 11.00 (5.00,40.00) | 22.82 (8.63,43.95) | 0.47 | 10.15 (2.98,27.89) | 27.45 (11.88,42.00) | 70.00 (55.13,73.48) | 5.64E-03 | 16.13 (4.36,50.00) | 21.90 (10.00,38.90) | 0.55 |